Published in AIDS Weekly, March 30th, 1998
The results come from a very small study over the course of only one year. They require verification in studies with larger numbers of patients carried out over longer periods of time.
"These findings argue that HIV replication differs significantly between patients on potent antiretroviral therapy with plasma RNA levels of <20 copies/mL, those with 20 to 400 copies/mL, and those with >400 copies/mL," wrote University of San Diego researchers Huldrych F. Gunthard, Douglas D. Richman, and colleagues.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.